Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TET3 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | ADNP2 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | SNAP25 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | KCNB2 | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-07 |
mRNA | GIGYF1 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-07 |
mRNA | ZIK1 | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | CERKL | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
mRNA | RNF183 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-07 |
mRNA | AGO4 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | ARHGAP45 | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-07 |